Small molecules & peptides
(R)-(–)-Norapomorphine hydrobromide
Precursor for [¹¹C]-(–)-NPA and [¹¹C]-(–)-NMA ([¹¹C]-(–)-N-propyl-norapomorphine and [¹¹C]-(–)-N-methyl-norapomorphine)
4H-Dibenzo[de,g]quinoline-10,11-diol, 5,6,6a,7-tetrahydro-, hydrobromide, (R)-; (R)-(–)-Norapomorphine hydrobromide; (R)-(–)-Norapomorphine · HBr
CA index name: 4H-Dibenzo[de,g]quinoline-10,11-diol, 5,6,6a,7-tetrahydro-, hydrobromide, (6aR)-
Quality
Research Chemical
Characteristics
Molar mass 334.21
CAS RN [115017-61-3]
Purity ≥ 95 %
- Colorless to yellowish solid
Certificates
CoA: appearance, ¹H NMR spectrum
Literature
Hwang D.-R. et al. (–)-N-[¹¹C]propyl-norapomorphine: a positron-labeled dopamine agonist for PET imaging of D2 receptors. Nucl. Med. Biol. 2000, 27, 533–539.
Narendran R. et al. In vivo vulnerability to competition by endogenous dopamine: Comparison of the D2 receptor agonist radiotracer (–)-N-[¹¹C]propyl-norapomorphine ([¹¹C]NPA) with the D2 receptor antagonist radiotracer [¹¹C]-raclopride. Synapse 2004, 52, 188–208.
Zijlstra S. et al. Synthesis and in vivo distribution in the rat of a dopamine agonist: N-([¹¹C]methyl)norapomorphine. Nucl. Med. Biol. 1993, 20, 7–12.
Add to inquiry
| Product | Product No. | Filling amount | Quantity | ||
|---|---|---|---|---|---|
| /products/small-molecules-and-peptides/chemical/6b868304-430d-4392-8535-f1131eb76b92 | Precursor | Product No.: 1477 | Filling amount: 2 mg | ||
| /products/small-molecules-and-peptides/chemical/6b868304-430d-4392-8535-f1131eb76b92 | Precursor | Product No.: 1477 |
Product was added